Cite

HARVARD Citation

    Shiffman, D. et al. (2015). Genetic risk for atrial fibrillation could motivate patient adherence to warfarin therapy: a cost effectiveness analysis. BMC cardiovascular disorders. 15 (1), pp. 1-7. [Online]. 
  
Back to record